Sarah Fletcher Mercaldo, Ph.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Mammography | 13 | 2023 | 2476 | 0.730 |
Why?
|
Technology, Radiologic | 1 | 2019 | 163 | 0.680 |
Why?
|
Breast Neoplasms | 24 | 2023 | 20822 | 0.680 |
Why?
|
Thoracic Diseases | 1 | 2019 | 97 | 0.660 |
Why?
|
Back Pain | 1 | 2021 | 545 | 0.600 |
Why?
|
Decision Support Systems, Clinical | 1 | 2021 | 1164 | 0.410 |
Why?
|
Magnetic Resonance Imaging | 10 | 2023 | 35421 | 0.360 |
Why?
|
Carcinoma, Intraductal, Noninfiltrating | 3 | 2022 | 949 | 0.350 |
Why?
|
Carcinoma, Ductal, Breast | 3 | 2022 | 1101 | 0.350 |
Why?
|
Biostatistics | 1 | 2020 | 162 | 0.320 |
Why?
|
Early Detection of Cancer | 12 | 2023 | 3086 | 0.310 |
Why?
|
Delayed Diagnosis | 2 | 2021 | 441 | 0.310 |
Why?
|
Emergency Service, Hospital | 3 | 2023 | 7659 | 0.260 |
Why?
|
Breast | 8 | 2022 | 1969 | 0.260 |
Why?
|
Astronauts | 2 | 2022 | 79 | 0.250 |
Why?
|
Hospitalization | 1 | 2021 | 10262 | 0.200 |
Why?
|
Lumbar Vertebrae | 2 | 2021 | 1848 | 0.200 |
Why?
|
Weightlessness | 1 | 2022 | 87 | 0.200 |
Why?
|
Retrospective Studies | 27 | 2023 | 77449 | 0.190 |
Why?
|
Healthcare Disparities | 3 | 2021 | 3158 | 0.180 |
Why?
|
Data Interpretation, Statistical | 1 | 2020 | 2716 | 0.180 |
Why?
|
Space Flight | 1 | 2022 | 188 | 0.180 |
Why?
|
Communication Barriers | 1 | 2023 | 398 | 0.180 |
Why?
|
Pneumothorax | 1 | 2022 | 379 | 0.170 |
Why?
|
Ultrasonography, Mammary | 1 | 2021 | 250 | 0.170 |
Why?
|
Choristoma | 1 | 2020 | 213 | 0.170 |
Why?
|
Adenocarcinoma, Papillary | 1 | 2019 | 84 | 0.160 |
Why?
|
Carcinoma, Pancreatic Ductal | 2 | 2020 | 1634 | 0.160 |
Why?
|
Behavioral Risk Factor Surveillance System | 1 | 2019 | 199 | 0.160 |
Why?
|
Sensitivity and Specificity | 7 | 2021 | 14722 | 0.160 |
Why?
|
Mass Screening | 7 | 2023 | 5255 | 0.150 |
Why?
|
Utilization Review | 1 | 2019 | 392 | 0.150 |
Why?
|
Middle Aged | 27 | 2023 | 213383 | 0.140 |
Why?
|
Models, Statistical | 2 | 2020 | 5102 | 0.140 |
Why?
|
Aged | 23 | 2023 | 163280 | 0.140 |
Why?
|
Elasticity Imaging Techniques | 1 | 2021 | 388 | 0.140 |
Why?
|
Multiple Pulmonary Nodules | 1 | 2018 | 153 | 0.130 |
Why?
|
Lung Neoplasms | 4 | 2023 | 13102 | 0.130 |
Why?
|
Idiopathic Pulmonary Fibrosis | 1 | 2021 | 451 | 0.130 |
Why?
|
Lung Diseases, Interstitial | 1 | 2023 | 808 | 0.130 |
Why?
|
Solitary Pulmonary Nodule | 1 | 2018 | 266 | 0.120 |
Why?
|
Biomedical Research | 1 | 2020 | 3309 | 0.120 |
Why?
|
Prostate | 1 | 2022 | 1774 | 0.120 |
Why?
|
Workload | 1 | 2019 | 850 | 0.110 |
Why?
|
Female | 33 | 2023 | 380194 | 0.110 |
Why?
|
Pneumonectomy | 1 | 2020 | 1094 | 0.110 |
Why?
|
Humans | 43 | 2023 | 744343 | 0.110 |
Why?
|
Venous Thrombosis | 1 | 2022 | 1239 | 0.110 |
Why?
|
Mastectomy, Segmental | 3 | 2022 | 956 | 0.100 |
Why?
|
Low Back Pain | 1 | 2021 | 956 | 0.100 |
Why?
|
Adult | 18 | 2023 | 214055 | 0.100 |
Why?
|
Pancreatic Neoplasms | 2 | 2020 | 5256 | 0.100 |
Why?
|
Calcinosis | 1 | 2020 | 1499 | 0.100 |
Why?
|
Pneumonia | 1 | 2023 | 2133 | 0.100 |
Why?
|
Image Interpretation, Computer-Assisted | 2 | 2021 | 3327 | 0.100 |
Why?
|
Predictive Value of Tests | 3 | 2021 | 15076 | 0.090 |
Why?
|
C-Reactive Protein | 1 | 2021 | 3778 | 0.090 |
Why?
|
Thrombosis | 1 | 2022 | 2968 | 0.080 |
Why?
|
Ambulatory Care | 1 | 2019 | 2708 | 0.080 |
Why?
|
Prospective Studies | 6 | 2022 | 53288 | 0.080 |
Why?
|
Image Enhancement | 1 | 2019 | 2921 | 0.080 |
Why?
|
Insurance, Health | 1 | 2019 | 2494 | 0.070 |
Why?
|
Male | 15 | 2023 | 350118 | 0.070 |
Why?
|
Lung | 2 | 2023 | 9856 | 0.070 |
Why?
|
Biopsy, Needle | 2 | 2022 | 1641 | 0.060 |
Why?
|
Observer Variation | 2 | 2021 | 2593 | 0.060 |
Why?
|
Medicare | 1 | 2023 | 6566 | 0.060 |
Why?
|
Carcinoma, Non-Small-Cell Lung | 1 | 2023 | 5221 | 0.060 |
Why?
|
Diagnostic Imaging | 1 | 2019 | 3507 | 0.060 |
Why?
|
Practice Guidelines as Topic | 1 | 2021 | 7279 | 0.060 |
Why?
|
United States National Aeronautics and Space Administration | 1 | 2022 | 15 | 0.050 |
Why?
|
Substance-Related Disorders | 1 | 2019 | 4258 | 0.050 |
Why?
|
Analgesics, Opioid | 1 | 2019 | 3674 | 0.050 |
Why?
|
Reproducibility of Results | 4 | 2021 | 19905 | 0.050 |
Why?
|
Architectural Accessibility | 1 | 2021 | 24 | 0.050 |
Why?
|
Mental Disorders | 1 | 2022 | 6600 | 0.050 |
Why?
|
Neoplasm Invasiveness | 2 | 2020 | 3616 | 0.050 |
Why?
|
Aged, 80 and over | 6 | 2022 | 57776 | 0.050 |
Why?
|
Jugular Veins | 1 | 2022 | 204 | 0.050 |
Why?
|
Tomography, X-Ray Computed | 2 | 2021 | 20129 | 0.050 |
Why?
|
Diagnosis, Differential | 3 | 2021 | 12959 | 0.050 |
Why?
|
Mucin 5AC | 1 | 2020 | 93 | 0.050 |
Why?
|
Computers | 1 | 2022 | 612 | 0.040 |
Why?
|
Time | 1 | 2021 | 542 | 0.040 |
Why?
|
Lumbosacral Region | 1 | 2021 | 310 | 0.040 |
Why?
|
Prostatic Neoplasms | 1 | 2022 | 11124 | 0.040 |
Why?
|
Pancreatic Ducts | 1 | 2020 | 328 | 0.040 |
Why?
|
Odds Ratio | 2 | 2022 | 9849 | 0.040 |
Why?
|
United States | 6 | 2023 | 69872 | 0.040 |
Why?
|
Time Factors | 1 | 2019 | 40075 | 0.040 |
Why?
|
Logistic Models | 2 | 2022 | 13408 | 0.040 |
Why?
|
Obesity | 1 | 2019 | 12745 | 0.040 |
Why?
|
Feedback | 1 | 2020 | 795 | 0.040 |
Why?
|
Cardiovascular Diseases | 1 | 2022 | 15165 | 0.030 |
Why?
|
Risk Factors | 5 | 2022 | 72290 | 0.030 |
Why?
|
Radiography, Thoracic | 1 | 2022 | 1265 | 0.030 |
Why?
|
False Positive Reactions | 1 | 2018 | 981 | 0.030 |
Why?
|
Risk Assessment | 3 | 2022 | 23338 | 0.030 |
Why?
|
Neoplasm Recurrence, Local | 2 | 2022 | 9239 | 0.030 |
Why?
|
Language | 1 | 2023 | 1471 | 0.030 |
Why?
|
Mastectomy | 1 | 2021 | 1793 | 0.030 |
Why?
|
Carcinoma in Situ | 1 | 2019 | 806 | 0.030 |
Why?
|
Needs Assessment | 1 | 2019 | 1147 | 0.030 |
Why?
|
Xenograft Model Antitumor Assays | 1 | 2020 | 3557 | 0.030 |
Why?
|
Prostate-Specific Antigen | 1 | 2022 | 2494 | 0.030 |
Why?
|
Probability | 1 | 2018 | 2505 | 0.030 |
Why?
|
Tumor Burden | 1 | 2018 | 1915 | 0.030 |
Why?
|
Benchmarking | 1 | 2018 | 1042 | 0.030 |
Why?
|
Radiography | 1 | 2022 | 7023 | 0.020 |
Why?
|
Pandemics | 2 | 2021 | 8388 | 0.020 |
Why?
|
Radiographic Image Interpretation, Computer-Assisted | 1 | 2018 | 1184 | 0.020 |
Why?
|
Body Composition | 1 | 2020 | 2401 | 0.020 |
Why?
|
Reoperation | 1 | 2020 | 4201 | 0.020 |
Why?
|
Program Evaluation | 1 | 2019 | 2488 | 0.020 |
Why?
|
Artificial Intelligence | 1 | 2022 | 2214 | 0.020 |
Why?
|
Fluorodeoxyglucose F18 | 1 | 2018 | 2016 | 0.020 |
Why?
|
Biopsy | 1 | 2021 | 6756 | 0.020 |
Why?
|
Societies, Medical | 1 | 2021 | 3743 | 0.020 |
Why?
|
Cross-Sectional Studies | 2 | 2020 | 25043 | 0.020 |
Why?
|
Linear Models | 1 | 2019 | 5952 | 0.020 |
Why?
|
Academic Medical Centers | 1 | 2019 | 2759 | 0.020 |
Why?
|
Radiopharmaceuticals | 1 | 2018 | 2645 | 0.020 |
Why?
|
Insurance Coverage | 1 | 2019 | 1901 | 0.020 |
Why?
|
Cohort Studies | 2 | 2020 | 40561 | 0.020 |
Why?
|
Length of Stay | 1 | 2020 | 6309 | 0.020 |
Why?
|
Hospitals | 1 | 2020 | 3952 | 0.020 |
Why?
|
Contrast Media | 1 | 2019 | 5300 | 0.020 |
Why?
|
Longitudinal Studies | 1 | 2022 | 13989 | 0.020 |
Why?
|
Multivariate Analysis | 1 | 2019 | 12245 | 0.020 |
Why?
|
Computer Simulation | 1 | 2019 | 6196 | 0.020 |
Why?
|
Survival Analysis | 1 | 2018 | 10252 | 0.020 |
Why?
|
Imaging, Three-Dimensional | 1 | 2018 | 4042 | 0.020 |
Why?
|
Young Adult | 2 | 2021 | 56430 | 0.010 |
Why?
|
Age Factors | 1 | 2019 | 18370 | 0.010 |
Why?
|
Health Services Accessibility | 1 | 2019 | 5137 | 0.010 |
Why?
|
Prevalence | 1 | 2019 | 15226 | 0.010 |
Why?
|
Child, Preschool | 1 | 2022 | 41006 | 0.010 |
Why?
|
Follow-Up Studies | 1 | 2020 | 39050 | 0.010 |
Why?
|
Postoperative Complications | 1 | 2020 | 15295 | 0.010 |
Why?
|
Adolescent | 1 | 2022 | 85781 | 0.010 |
Why?
|
Mice | 1 | 2020 | 81183 | 0.010 |
Why?
|
Animals | 1 | 2020 | 168757 | 0.010 |
Why?
|